Johan Rosell

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

Annika Malmström, Bjørn Henning Grønberg, Christine Marosi et al. · The Lancet Oncology · 2012 · 1.2K citations

Neuro-oncology, Radiation Medicine, Radiation Therapy +8

Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades

Làszló Tabár, Bedrich Viták, Amy Ming‐Fang Yen et al. · Radiology · 2011 · 777 citations

Reliability of death certificates in prostate cancer patients

Katja Fall, Fredrik Strömberg, Johan Rosell et al. · Scandinavian Journal of Urology and Nephrology · 2008 · 114 citations

Clinical Consequences of Screening for Prostate Cancer: 15 Years Follow-up of a Randomised Controlled Trial in Sweden

Gabriel Sandblom, Eberhard Varenhorst, Owe Löfman et al. · European Urology · 2004 · 102 citations

Urology, Cancer Detection, Controlled Trial +9

Coronary Heart Disease Mortality After 5 Years of Adjuvant Tamoxifen Therapy: Results from a Randomized Trial

Bo Nordenskjöld, Johan Rosell, Lars‐Erik Rutqvist et al. · JNCI Journal of the National Cancer Institute · 2005 · 70 citations · Full text

Heart Failure, Surgical Oncology, Breast Oncology +22